84 Odcinki

  1. Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

    Opublikowany: 10.01.2025
  2. Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures

    Opublikowany: 12.12.2024
  3. Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis

    Opublikowany: 6.11.2024
  4. Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease

    Opublikowany: 1.11.2024
  5. Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

    Opublikowany: 31.07.2024
  6. Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

    Opublikowany: 1.07.2024
  7. Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

    Opublikowany: 17.05.2024
  8. Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

    Opublikowany: 7.05.2024
  9. Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

    Opublikowany: 22.04.2024
  10. Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

    Opublikowany: 12.03.2024
  11. Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

    Opublikowany: 1.03.2024
  12. Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

    Opublikowany: 19.12.2023
  13. Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy

    Opublikowany: 29.11.2023
  14. Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease

    Opublikowany: 12.10.2023
  15. Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction

    Opublikowany: 13.09.2023
  16. Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis

    Opublikowany: 10.08.2023
  17. Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease

    Opublikowany: 12.07.2023
  18. Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis

    Opublikowany: 7.06.2023
  19. Adelina Artenie on the incidence of HIV and HCV in people who inject drugs

    Opublikowany: 10.05.2023
  20. Johan Burisch on the costs of inflammatory bowel disease in high-income settings

    Opublikowany: 12.04.2023

1 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site